Prostate cancer patients are a heterogeneous group with a prognosis ranging from full recovery to malignant and lethal disease. Between 2007 and 2014, the number of prostate cancers diagnosed declined due to changes in screening…
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Submission received: 8 February 2024
/
Revised: 12 March 2024
/
Accepted: 20 March 2024
/
Published: 28 March 2024
Abstract
This study…
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open AccessArticle
by
1,2,*, 2, 2,3, 4, 5, 6, 7 and 8,9,*
1
Department of Clinical Oncology, Wroclaw Medical…
ROYAL OAK, Mich.--(BUSINESS WIRE)--Immunis.AI Announces Publication, in The Journal of Urology, of Results from Blood-Based Immune Profiling Study for Prostate Cancer Patients
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines.
Biomedicines, Vol. 12, Pages 418: Epithelial-Mesenchymal Transition: A Fundamental Cellular and Microenvironmental Process in Benign and Malignant Prostate Pathologies
Biomedicines doi: 10.3390/biomedicines12020418
Authors:
Aviv…
February 8, 2024 — Lorelei Mucci, professor of epidemiology at Harvard T.H. Chan School of Public Health, has spent her career seeking to understand why prostate cancer occurs, how it can be prevented, and what patients can do to…
Viruses, Vol. 16, Pages 277: Phage Display’s Prospects for Early Diagnosis of Prostate Cancer
Viruses doi: 10.3390/v16020277
Authors:
Valery A. Petrenko
Prostate cancer (PC) is the second most diagnosed cancer among…
The clinically advanced treatment program helps patients maintain or regain their sexual function after prostate surgery.
We’ve built an extensive rehabilitation protocol which has been scientifically validated through multiple…
At a Glance
Men with cancer confined to the prostate experienced different long-term side effects depending on the type of treatment received.
Understanding the pros and cons of different treatments may help men and their health care…
This study analyzed a previously published cohort of men whose age ranged between 35 and 92 years old and who had a median age of 63 years and analyzed a specific combination of markers for the investigation of its utility in Caucasian…
The androgen receptor (AR), NR3C4 (nuclear receptor subfamily 3, group C, gene 4), is an androgen-dependent transcription factor with four functional domains: the ligand binding domain, DNA binding domain, hinge region, and N-terminal…
1. IntroductionProstate cancer (PCa) is a significant global healthcare concern, with an estimated 288,300 new cases reported in the United States in 2023 . In the 1990s, we witnessed a sudden increase in the incidence of this disease,…
1. IntroductionProstate cancer (PCa) is a significant global healthcare concern, with an estimated 288,300 new cases reported in the United States in 2023 . In the 1990s, we witnessed a sudden increase in the incidence of this disease,…
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight…
1. IntroductionIn the last decades, due to widespread screening practices, prostate cancer (PCa) has recently been identified at earlier stages. Although drastic procedures, such as radical prostatectomy (RP) and external beam radiation…
1. IntroductionProstate cancer (PCa) is the most common cancer in men in Western countries, accounting for about 25% of new cancer diagnoses . Since 2020, the European Association of Urology added a strong recommendation to perform…
The prognosis of patients with metastatic prostate cancer is approximately 42 months , and the patient often eventually develops bone metastases, with autopsy results showing bone metastases in over 90% of cases . Bone metastases are…
1. IntroductionPatients with intermediate-risk prostate cancer have a variety of treatment options available to them, such as surgery, brachytherapy, and external beam radiotherapy (EBRT). As overall survival outcomes between these…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
AcceptRead More